About the Company
versartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. versartis’ mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. learn more at www.versartis.com.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ARAV News
CORRECTING and REPLACING PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical
The updated release reads: PHARMAESSENTIA APPOINTS ROBERT GELLER, M.D. AS HEAD OF MEDICAL. PharmaEssentia USA Corporation, a ...
Why Is Aravive Stock Sinking Today?
Aravive Inc (NASDAQ: ARAV) shares plunged after the company's Phase 3 AXLerate-OC trial evaluating the safety and efficacy of batiraxcept in platinum-resistant ovarian cancer did not meet its ...
PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical and Shawn Gibbs, J.D. as Head of Legal
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator ...
Aravive (ARAV) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Carisma Therapeutics Announces Changes to its Board of Directors
Inc. and Aravive, Inc. Dr. Hohneker received his bachelor's degree in chemistry from Gettysburg College and his M.D. from the Rutgers School of Biomedical and Health Sciences (formerly the ...
Aravive Receives Third Development Milestone from 3D Medicines
Aravive Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, today announced that it received a $6 million development ...
Shahzad Malik's Net Worth
Conatus Pharmaceuticals Inc, and Aravive, Inc.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and ...
Aravive, Inc. (ARAV)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
APTO Aptose Biosciences Inc.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States.
Why Is Nuvve (NVVE) Stock Down 31% Today?
That includes what’s going on with shares of Aravive (NASDAQ:ARAV) stock, Marpai (NASDAQ:MRAI) stock and Lytus Technologies ...
Etsy Inc.
1 Day ETSY -0.46% DJIA 0.67% S&P 500 0.87% Retail/Wholesale 0.37% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Loading the latest forecasts...